11 Sept 2026 Logan Pharmaceuticals
Rasonque (Daraxonrasib): From FDA Approval to Promising New Directions in Cancer Treatment
The treatment landscape for RAS-driven cancers is entering a new phase. RAS proteins have long been recognised as major drivers of tumour growth, but directly targeting the RA...
Read article